Fresenius Medical Care AG & Co. (FMS)
(Delayed Data from NYSE)
$21.09 USD
+0.91 (4.51%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $21.08 -0.01 (-0.05%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth D Momentum A VGM
Brokerage Reports
Fresenius Medical Care AG & Co. KGaA [FMS]
Reports for Purchase
Showing records 121 - 140 ( 148 total )
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Inline 4Q13 results; 2014 guidance fails to impress as margin pressure increases
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
CMS finalized dialysis rebasing with a four year phase-in period
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
3Q13 largely inline with expectations; rebasing overhang continues
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Fireworks start early as CMS proposed ESRD rule worse than expected
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Weak 1Q13 results; we see no reason to step in, maintain HOLD
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
3Q12 results disappoint on the top and bottom line; maintaining HOLD
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
FMS 4Q highlights solid operating results; 2012 guidance inline
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Survey sees further opportunity to reduce patient costs; near-term margin expansion?
Provider: FELTL & COMPANY
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Facility survey: Changes are underway and more diverse than expected
Provider: FELTL & COMPANY
Analyst: HOERNEMANN J
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Eastern European acquisition looks expensive, but will likely be accretive
Provider: FELTL & COMPANY
Analyst: HOERNEMANN J